{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:32:18Z","timestamp":1792733538011,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21H05173"],"award-info":[{"award-number":["JP21H05173"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although vaccination has significantly contributed to controlling the coronavirus disease 2019 (COVID-19) infections, a high risk of side effects has resulted in vaccination hesitancy. Nevertheless, as COVID-19 has become common but still has a severe impact on vulnerable people, we might need to follow a long-term vaccination routine. Therefore, elucidating the characteristics of individuals who may exhibit either vulnerability or resilience to the side effects associated with COVID-19 vaccinations is of the utmost importance for the vaccination plan against COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Self-reported data on demographics, physical health, addictive lifestyle habits, mental health, and side effects were collected online. For 998 participants who received two vaccination doses, we performed repeated measures ANOVA, including side effects scores as dependent variables and individual characteristics as independent variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found interactions between vaccine dose and history of suspected lifestyle diseases (F\u2009=\u20094.460, <jats:italic>p<\/jats:italic>\u2009=\u20090.012) or trait anxiety (F\u2009=\u20095.548, <jats:italic>p<\/jats:italic>\u2009=\u20090.019). Besides the aggregation of side effects after the second dose compared to the first dose, we found that increased side effects after vaccination were associated with specific personal factors: younger age (F\u2009=\u200918.973, <jats:italic>p<\/jats:italic>\u2009=\u20090.000), female sex (F\u2009=\u200934.507, <jats:italic>p<\/jats:italic>\u2009=\u20090.000), low BMI (F\u2009=\u20094.205, <jats:italic>p<\/jats:italic>\u2009=\u20090.015), no history of \u201cspecific health guidance\u201d (F\u2009=\u20095.004, <jats:italic>p<\/jats:italic>\u2009=\u20090.007) or smoking (F\u2009=\u20099.123, <jats:italic>p<\/jats:italic>\u2009=\u20090.003) or drinking (F\u2009=\u20093.335, <jats:italic>p<\/jats:italic>\u2009=\u20090.036), and higher levels of depressive symptoms (F\u2009=\u200915.134, <jats:italic>p<\/jats:italic>\u2009=\u20090.000) or trait anxiety (F\u2009=\u200926.350, <jats:italic>p<\/jats:italic>\u2009=\u20090.000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Physical characteristics and lifestyle habits linked with intact immune function enhanced side effects, whereas psychological characteristics linked with impaired immune function also enhanced side effects. These seemingly contradictory results could be explained at least partly by nocebo effects and suggest the need for psychological support for people with high levels of depressive symptoms or trait anxiety. Furthermore, interaction results imply that such support might be especially beneficial to those who are young and unaffected by lifestyle diseases while simultaneously showing high trait anxiety.\u00a0<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40359-025-03325-4","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:39:19Z","timestamp":1756712359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissociable impacts of physical and psychological factors on side effects after COVID-19 vaccination in Japan: A within-subject repeated measures design"],"prefix":"10.1186","volume":"13","author":[{"given":"Kosuke","family":"Tsurumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Uwatoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"3325_CR1","doi-asserted-by":"publisher","first-page":"CD015477","DOI":"10.1002\/14651858.CD015477","volume":"12","author":"C Gra\u00f1a","year":"2022","unstructured":"Gra\u00f1a C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12:CD015477. https:\/\/doi.org\/10.1002\/14651858.CD015477.","journal-title":"Cochrane Database Syst Rev"},{"key":"3325_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1473-3099(21)00224-3","volume":"3099","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;3099:1\u201311. https:\/\/doi.org\/10.1016\/s1473-3099(21)00224-3.","journal-title":"Lancet Infect Dis"},{"key":"3325_CR3","unstructured":"World Health Organization. COVID-19 Epidemiological Update Edition 166 published 12 April 2024. 2024."},{"key":"3325_CR4","unstructured":"Influenza ( Seasonal ). 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal). Accessed 2 Jul 2024."},{"key":"3325_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/d41586-021-00290-x","volume":"590","author":"A Remmel","year":"2021","unstructured":"Remmel A. COVID vaccines and safety: what the research says. Nature. 2021;590:538\u201340. https:\/\/doi.org\/10.1038\/d41586-021-00290-x.","journal-title":"Nature"},{"key":"3325_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0974-777X.77299","volume":"3","author":"AS Clem","year":"2011","unstructured":"Clem AS. Fundamentals of vaccine immunology. J Glob Infect Dis. 2011;3:73\u20138. https:\/\/doi.org\/10.4103\/0974-777X.77299.","journal-title":"J Glob Infect Dis"},{"key":"3325_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14760584.2022.2008245","volume":"21","author":"M Abdalla","year":"2022","unstructured":"Abdalla M, El-Arabey AA, Jiang X. What are the challenges faced by COVID-19 vaccines? Expert Rev Vaccines. 2022;21:5\u20137. https:\/\/doi.org\/10.1080\/14760584.2022.2008245.","journal-title":"Expert Rev Vaccines"},{"key":"3325_CR8","unstructured":"Janeway CA, Travers P, Walport M, Capra DJ. Immunobiology. Taylor & Francis Group UK: Garland Science. 2001."},{"key":"3325_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ni.2588","volume":"14","author":"JJ Goronzy","year":"2013","unstructured":"Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14:428\u201336. https:\/\/doi.org\/10.1038\/ni.2588.","journal-title":"Nat Immunol"},{"key":"3325_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"3325_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1467-789x.2001.00025.x","volume":"2","author":"A Mart\u00ed","year":"2001","unstructured":"Mart\u00ed A, Marcos A, Mart\u00ednez JA. Obesity and immune function relationships. Obes Rev. 2001;2:131\u201340. https:\/\/doi.org\/10.1046\/j.1467-789x.2001.00025.x.","journal-title":"Obes Rev"},{"key":"3325_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","volume":"366","author":"T Jefferson","year":"2005","unstructured":"Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(05)67339-4.","journal-title":"Lancet"},{"key":"3325_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005374","volume":"12","author":"LG vom Steeg","year":"2016","unstructured":"vom Steeg LG, Klein SL. Sexx matters in infectious disease pathogenesis. PLoS Pathog. 2016;12:1\u20136. https:\/\/doi.org\/10.1371\/journal.ppat.1005374.","journal-title":"PLoS Pathog"},{"key":"3325_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ijo.2011.208","volume":"36","author":"PA Sheridan","year":"2012","unstructured":"Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. 2012;36:1072\u20137. https:\/\/doi.org\/10.1038\/ijo.2011.208.","journal-title":"Int J Obes"},{"key":"3325_CR15","first-page":"159","volume":"37","author":"G Szabo","year":"2015","unstructured":"Szabo G, Saha B. Alcohol\u2019s effect on host defense. Alcohol Res Curr Rev. 2015;37:159\u201370.","journal-title":"Alcohol Res Curr Rev"},{"key":"3325_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nri803","volume":"2","author":"M Sopori","year":"2002","unstructured":"Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372\u20137. https:\/\/doi.org\/10.1038\/nri803.","journal-title":"Nat Rev Immunol"},{"key":"3325_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.510260332","volume":"26","author":"M Geissler","year":"1997","unstructured":"Geissler M, Gesien A, Wands JR. Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: an immunologic mechanism for induction of persistent viral infection in alcoholics. Hepatology. 1997;26:764\u201370. https:\/\/doi.org\/10.1002\/hep.510260332.","journal-title":"Hepatology"},{"key":"3325_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/thx.42.4.241","volume":"42","author":"PG Holt","year":"1987","unstructured":"Holt PG. Immune and inflammatory function in cigarette smokers. Thorax. 1987;42:241\u20139. https:\/\/doi.org\/10.1136\/thx.42.4.241.","journal-title":"Thorax"},{"key":"3325_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0264-410X(94)90283-6","volume":"12","author":"AP Winter","year":"1994","unstructured":"Winter AP, Follett EAC, McIntyre J, Stewart J, Symington IS. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine. 1994;12:771\u20132. https:\/\/doi.org\/10.1016\/0264-410X(94)90283-6.","journal-title":"Vaccine"},{"key":"3325_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-m","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11\u201338. https:\/\/doi.org\/10.1016\/0278-5846(94)00101-m.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3325_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/157339510791823835","volume":"6","author":"BE Leonard","year":"2010","unstructured":"Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev. 2010;6:205\u201312. https:\/\/doi.org\/10.2174\/157339510791823835.","journal-title":"Curr Immunol Rev"},{"key":"3325_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychores.2006.07.030","volume":"62","author":"L Arranz","year":"2007","unstructured":"Arranz L, Guayerbas N, De la Fuente M. Impairment of several immune functions in anxious women. J Psychosom Res. 2007;62:1\u20138. https:\/\/doi.org\/10.1016\/j.jpsychores.2006.07.030.","journal-title":"J Psychosom Res"},{"key":"3325_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hup.1259","volume":"27","author":"R Hou","year":"2012","unstructured":"Hou R, Baldwin DS. A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol Clin Exp. 2012;27:6\u201314. https:\/\/doi.org\/10.1002\/hup.1259.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"3325_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PSY.0b013e31819d1910","volume":"71","author":"S Gallagher","year":"2009","unstructured":"Gallagher S, Phillips AC, Drayson MT, Carroll D. Caregiving for children with developmental disabilities is associated with a poor antibody response to influenza vaccination. Psychosom Med. 2009;71:341\u20134. https:\/\/doi.org\/10.1097\/PSY.0b013e31819d1910.","journal-title":"Psychosom Med"},{"key":"3325_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1749-6632.1998.tb09603.x","volume":"840","author":"R Glaser","year":"1998","unstructured":"Glaser R, Kiecolt-Glaser JK, Malarkey WB, Sheridan JF. The influence of psychological stress on the immune response to vaccines. Ann N Y Acad Sci. 1998;840:649\u201355. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb09603.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3325_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbi.2008.05.006","volume":"23","author":"S Gallagher","year":"2009","unstructured":"Gallagher S, Phillips AC, Drayson MT, Carroll D. Parental caregivers of children with developmental disabilities mount a poor antibody response to pneumococcal vaccination. Brain Behav Immun. 2009;23(3):338\u201346. https:\/\/doi.org\/10.1016\/j.bbi.2008.05.006.","journal-title":"Brain Behav Immun"},{"key":"3325_CR27","doi-asserted-by":"publisher","first-page":"10\u20137","DOI":"10.3390\/vaccines10040566","volume":"10","author":"SH Loosen","year":"2022","unstructured":"Loosen SH, Bohlken J, Weber K, Konrad M, Luedde T, Roderburg C, et al. Factors associated with non-severe adverse reactions after vaccination against SARS-CoV-2: a cohort study of 908,869 outpatient vaccinations in Germany. Vaccines. 2022;10:10\u20137. https:\/\/doi.org\/10.3390\/vaccines10040566.","journal-title":"Vaccines"},{"key":"3325_CR28","doi-asserted-by":"publisher","unstructured":"Fox A, Carolan L, Leung V, Phuong HVM, Khvorov A, Auladell M, et al. Opposing effects of prior infection versus prior vaccination on vaccine immunogenicity against influenza A(H3N2) viruses. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14030470.","DOI":"10.3390\/v14030470"},{"key":"3325_CR29","doi-asserted-by":"publisher","first-page":"ofac314","DOI":"10.1093\/ofid\/ofac314","volume":"9","author":"AI Scher","year":"2022","unstructured":"Scher AI, Berjohn CM, Byrne C, Colombo RE, Colombo CJ, Edwards MS, et al. An analysis of SARS-CoV-2 vaccine reactogenicity: variation by type, dose, and history, severity, and recency of prior SARS-CoV-2 infection. Open Forum Infect Dis. 2022;9:ofac314. https:\/\/doi.org\/10.1093\/ofid\/ofac314.","journal-title":"Open Forum Infect Dis"},{"key":"3325_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1586\/14760584.7.4.467","volume":"7","author":"R Kumar","year":"2008","unstructured":"Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines. 2008;7:467\u201379. https:\/\/doi.org\/10.1586\/14760584.7.4.467.","journal-title":"Expert Rev Vaccines"},{"key":"3325_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","volume":"16","author":"SN Crooke","year":"2019","unstructured":"Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:25. https:\/\/doi.org\/10.1186\/s12979-019-0164-9.","journal-title":"Immun Ageing"},{"key":"3325_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41541-024-00874-4","volume":"9","author":"Y Hou","year":"2024","unstructured":"Hou Y, Chen M, Bian Y, Hu Y, Chuan J, Zhong L, et al. Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies. NPJ Vaccines. 2024;9:77. https:\/\/doi.org\/10.1038\/s41541-024-00874-4.","journal-title":"NPJ Vaccines"},{"key":"3325_CR33","unstructured":"National Health and Nutrition Survey in Japan, 2023 [in Japanese]. Tokyo. 2024."},{"key":"3325_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12979-024-00480-x","volume":"21","author":"S-T Chang","year":"2024","unstructured":"Chang S-T, Chuang Y-F, Li A-H, Fan Y-T, Liao M-R, Chen I-Y, et al. Age-dependent immune profile in healthy individuals: an original study, systematic review and meta-analysis. Immun Ageing. 2024;21:75. https:\/\/doi.org\/10.1186\/s12979-024-00480-x.","journal-title":"Immun Ageing"},{"key":"3325_CR35","volume-title":"Guidelines for the Management of Obesity Disease 2022","author":"Japan Society for the Study of Obesity","year":"2022","unstructured":"Japan Society for the Study of Obesity. Guidelines for the Management of Obesity Disease 2022. Tokyo, Japan (In Japanese): Life Science Publishing Company; 2022."},{"key":"3325_CR36","doi-asserted-by":"publisher","unstructured":"Examination Committee of Criteria for \u201cObesity disease\u201d in Japan, Japan society for the study of obesity. New criteria for \u201cobesity disease\u201d in Japan. Circ J. 2002;66:987\u201392. https:\/\/doi.org\/10.1253\/circj.66.987.","DOI":"10.1253\/circj.66.987"},{"key":"3325_CR37","doi-asserted-by":"publisher","unstructured":"OECD. \u201cOverweight and obesity\u201d, in Health at a Glance 2023: OECD Indicators,. Paris: OECD Publishing; 2023. p. 94\u20136. https:\/\/doi.org\/10.1787\/7a7afb35-en.","DOI":"10.1787\/7a7afb35-en"},{"key":"3325_CR38","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2337\/dc10-2300","volume":"34","author":"M Chiu","year":"2011","unstructured":"Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011;34:1741\u20138. https:\/\/doi.org\/10.2337\/dc10-2300.","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"3325_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1467-789X.2007.00439.x","volume":"9","author":"R Huxley","year":"2008","unstructured":"Huxley R, James WPT, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(Suppl. 1):53\u201361. https:\/\/doi.org\/10.1111\/j.1467-789X.2007.00439.x.","journal-title":"Obes Rev"},{"key":"3325_CR40","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.metabol.2009.03.021","volume":"58","author":"K Azuma","year":"2009","unstructured":"Azuma K, Kadowaki T, Cetinel C, Kadota A, El-Saed A, Kadowaki S, et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism. 2009;58:1200\u20137. https:\/\/doi.org\/10.1016\/j.metabol.2009.03.021.","journal-title":"Metabolism"},{"key":"3325_CR41","doi-asserted-by":"crossref","unstructured":"Mayfield, G. McLeod PH. Questionnaire\u202f: screening validation instrument of a new alcoholism. Am J Psychiatry. 1974; October:1121\u20133.","DOI":"10.1176\/ajp.131.10.1121"},{"key":"3325_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.genhosppsych.2013.08.001","volume":"35","author":"M Inagaki","year":"2013","unstructured":"Inagaki M, Ohtsuki T, Yonemoto N, Kawashima Y, Saitoh A, Oikawa Y, et al. Validity of the patient health questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study. Gen Hosp Psychiatry. 2013;35:592\u20137. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.08.001.","journal-title":"Gen Hosp Psychiatry"},{"key":"3325_CR43","unstructured":"Hidano T, Fukuhara M, Iwawaki S, Soga S, Spielberger CD. State-trait anxiety inventory-form JYZ Manual. Tokyo: Zitumukyouikusyuppann. 2000."},{"key":"3325_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"key":"3325_CR45","first-page":"283","volume":"22","author":"JH Block","year":"1976","unstructured":"Block JH. ISSUES, PROBLEMS, AND PITFALLS IN ASSESSING SEX DIFFERENCES: A CRITICAL REVIEW OF\" THE PSYCHOLOGY OF SEX DIFFERENCES\". Merrill Palmer Q Behav Dev. 1976;22:283\u2013308.","journal-title":"Merrill Palmer Q Behav Dev"},{"key":"3325_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/vaccines10030366","volume":"10","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Mohamud R, Fawaz M, Kateeb ET, et al. Reported adverse effects and attitudes among Arab populations following COVID-19 vaccination: a large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors. Vaccines. 2022;10:366. https:\/\/doi.org\/10.3390\/vaccines10030366.","journal-title":"Vaccines"},{"key":"3325_CR47","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.26355\/eurrev_202110_26871","volume":"25","author":"MG Garc\u00eda-Araiza","year":"2021","unstructured":"Garc\u00eda-Araiza MG, Martinez-Cuazitl A, Cid-Dominguez BE, Uribe-Nieto R, Ortega-Portillo R, Almeyda-Farf\u00e1n JA, et al. Side effects of the BNT162b2 vaccine in the personnel of the Military Central Hospital. Eur Rev Med Pharmacol Sci. 2021;25:5942\u20136. https:\/\/doi.org\/10.26355\/eurrev_202110_26871.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3325_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-14824-z","volume":"22","author":"MC Joyce","year":"2022","unstructured":"Joyce MC, Mountjoy NJ, Johnson JA, Newman JT, Bandy DL, Atalla NA, et al. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community. BMC Public Health. 2022;22:1\u201315. https:\/\/doi.org\/10.1186\/s12889-022-14824-z.","journal-title":"BMC Public Health"},{"key":"3325_CR49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","volume":"124","author":"B Pulendran","year":"2006","unstructured":"Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006;124:849\u201363. https:\/\/doi.org\/10.1016\/j.cell.2006.02.019.","journal-title":"Cell"},{"key":"3325_CR50","doi-asserted-by":"publisher","unstructured":"Canlas FQ, Nair S, Paat ID. Exploring COVID-19 vaccine side effects: a correlational study using python. Procedia Comput Sci. 2022;201 January:752\u20137. https:\/\/doi.org\/10.1016\/j.procs.2022.03.102.","DOI":"10.1016\/j.procs.2022.03.102"},{"key":"3325_CR51","doi-asserted-by":"publisher","first-page":"e013092","DOI":"10.1128\/spectrum.01309-22","volume":"10","author":"M Mori","year":"2022","unstructured":"Mori M, Yokoyama A, Shichida A, Sasuga K, Maekawa T, Moriyama T. Impact of sex and age on mRNA COVID-19 vaccine-related side effects in Japan. Microbiol Spectr. 2022;10:e013092. https:\/\/doi.org\/10.1128\/spectrum.01309-22.","journal-title":"Microbiol Spectr"},{"key":"3325_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10900-021-01039-3","volume":"47","author":"G Ripabelli","year":"2022","unstructured":"Ripabelli G, Tamburro M, Buccieri N, Adesso C, Caggiano V, Cannizzaro F, et al. Active surveillance of adverse events in healthcare workers recipients after vaccination with COVID-19 BNT162b2 vaccine (Pfizer-BioNTech, Comirnaty): a cross-sectional study. J Community Health. 2022;47:211\u201325. https:\/\/doi.org\/10.1007\/s10900-021-01039-3.","journal-title":"J Community Health"},{"key":"3325_CR53","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/vaccines10081357","volume":"10","author":"R Urakawa","year":"2022","unstructured":"Urakawa R, Isomura ET, Matsunaga K, Kubota K. Young age, female sex, and no comorbidities are risk factors for adverse reactions after the third dose of BNT162b2 COVID-19 vaccine against SARS-CoV-2: a prospective cohort study in Japan. Vaccines. 2022;10:1357. https:\/\/doi.org\/10.3390\/vaccines10081357.","journal-title":"Vaccines"},{"key":"3325_CR54","doi-asserted-by":"publisher","first-page":"e0091521","DOI":"10.1128\/msphere.00915-21","volume":"7","author":"R Zhang","year":"2022","unstructured":"Zhang R, Leung K-Y, Liu D, Fan Y, Lu L, Chan P-C, et al. Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines. mSphere. 2022;7:e0091521. https:\/\/doi.org\/10.1128\/msphere.00915-21.","journal-title":"mSphere"},{"key":"3325_CR55","doi-asserted-by":"crossref","unstructured":"Pellini R, Venuti A, Pimpinelli F, Abril E, Blandino G, Campo F, et al. Obesity May Hamper SARS-CoV-2 Vaccine immunogenicity: strategies for COVID-19. medRxiv. 2021;1\u201310.","DOI":"10.1101\/2021.02.24.21251664"},{"key":"3325_CR56","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1016\/j.vaccine.2021.09.055","volume":"39","author":"AK Singh","year":"2021","unstructured":"Singh AK, Phatak SR, Singh R, Bhattacharjee K, Singh NK, Gupta A, et al. Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM\u00ae) and BBV-152 (CovaxinTM\u00ae) among health care workers in India: the final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study. Vaccine. 2021;39:6492\u2013509. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.055.","journal-title":"Vaccine"},{"key":"3325_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01455","volume":"8","author":"Z Spolarics","year":"2017","unstructured":"Spolarics Z, Pe\u00f1a G, Qin Y, Donnelly RJ, Livingston DH. Inherent X-linked genetic variability and cellular mosaicism unique to females contribute to sex-related differences in the innate immune response. Front Immunol. 2017;8:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2017.01455.","journal-title":"Front Immunol"},{"key":"3325_CR58","doi-asserted-by":"publisher","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid BG, Almukadi HS, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021. https:\/\/doi.org\/10.2147\/IJGM.S310497.","DOI":"10.2147\/IJGM.S310497"},{"key":"3325_CR59","doi-asserted-by":"publisher","first-page":"1\u201318","DOI":"10.3390\/jcm10071428","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M. Prevalence of covid-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10:1\u201318. https:\/\/doi.org\/10.3390\/jcm10071428.","journal-title":"J Clin Med"},{"key":"3325_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines10122137","volume":"10","author":"A Riad","year":"2022","unstructured":"Riad A, Alsaad SS, Almurikhi AA, Alzahrani FA, Alghamdi AM, Alzaid EH, et al. Side effects of COVID-19 vaccines primer doses: experience of Saudi healthcare workers participating in CoVaST-SA. Vaccines. 2022;10:1\u201314. https:\/\/doi.org\/10.3390\/vaccines10122137.","journal-title":"Vaccines"},{"key":"3325_CR61","doi-asserted-by":"publisher","unstructured":"Wang J, Tong Y, Li D, Li J, Li Y. The impact of age difference on the efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.758294.","DOI":"10.3389\/fimmu.2021.758294"},{"key":"3325_CR62","doi-asserted-by":"publisher","first-page":"e27297","DOI":"10.7759\/cureus.27297","volume":"14","author":"FH Ibrahim Amer","year":"2022","unstructured":"Ibrahim Amer FH, Alzayyat R, Alzayyat N, Alomran S, Wafai S, Alabssi H, et al. Side Effects of COVID-19 Vaccines (Pfizer, AstraZeneca) in Saudi Arabia. Eastern Province Cureus. 2022;14:e27297. https:\/\/doi.org\/10.7759\/cureus.27297.","journal-title":"Eastern Province Cureus"},{"key":"3325_CR63","doi-asserted-by":"publisher","first-page":"e3465","DOI":"10.1002\/dmrr.3465","volume":"38","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev. 2022;38:e3465. https:\/\/doi.org\/10.1002\/dmrr.3465.","journal-title":"Diabetes Metab Res Rev"},{"key":"3325_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11357-021-00323-3","volume":"43","author":"J Connors","year":"2021","unstructured":"Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience. 2021;43:31\u201351. https:\/\/doi.org\/10.1007\/s11357-021-00323-3.","journal-title":"Geroscience"},{"key":"3325_CR65","doi-asserted-by":"publisher","unstructured":"Frasca D, Blomberg BB. The impact of obesity and metabolic syndrome on vaccination success. in: vaccines for older adults: current practices and future opportunities. Karger Publishers; 2020. p. 86\u201397. https:\/\/doi.org\/10.1159\/000504440.","DOI":"10.1159\/000504440"},{"key":"3325_CR66","doi-asserted-by":"publisher","first-page":"1861.e1","DOI":"10.1016\/j.cmi.2021.07.042","volume":"27","author":"T Kageyama","year":"2021","unstructured":"Kageyama T, Ikeda K, Tanaka S, Taniguchi T, Igari H, Onouchi Y, et al. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan. Clin Microbiol Infect. 2021;27:1861.e1-1861.e5. https:\/\/doi.org\/10.1016\/j.cmi.2021.07.042.","journal-title":"Clin Microbiol Infect"},{"key":"3325_CR67","doi-asserted-by":"publisher","first-page":"107123","DOI":"10.1016\/j.ypmed.2022.107123","volume":"161","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto S, Tanaka A, Ohmagari N, Yamaguchi K, Ishitsuka K, Morisaki N, et al. Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers. Prev Med (Baltim). 2022;161:107123. https:\/\/doi.org\/10.1016\/j.ypmed.2022.107123.","journal-title":"Prev Med (Baltim)"},{"key":"3325_CR68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.puhe.2021.12.013","volume":"203","author":"P Ferrara","year":"2022","unstructured":"Ferrara P, Ponticelli D, Ag\u00fcero F, Caci G, Vitale A, Borrelli M, et al. Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies. Public Health. 2022;203:97\u20139. https:\/\/doi.org\/10.1016\/j.puhe.2021.12.013.","journal-title":"Public Health"},{"key":"3325_CR69","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1745691621989243","volume":"16","author":"AA Madison","year":"2021","unstructured":"Madison AA, Shrout MR, Renna ME, Kiecolt-Glaser JK. Psychological and behavioral predictors of vaccine efficacy: considerations for COVID-19. Perspect Psychol Sci. 2021;16:191\u2013203. https:\/\/doi.org\/10.1177\/1745691621989243.","journal-title":"Perspect Psychol Sci"},{"key":"3325_CR70","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbi.2022.09.004","volume":"107","author":"H Kaneko","year":"2023","unstructured":"Kaneko H, Tsuboi H. Depressive symptoms predict antibody titers after a second dose of the SARS-CoV-2 BNT162b2 vaccine among hospital workers in Japan. Brain Behav Immun. 2023;107:414\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2022.09.004.","journal-title":"Brain Behav Immun"},{"key":"3325_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.43955","volume":"5","author":"JW Haas","year":"2022","unstructured":"Haas JW, Bender FL, Ballou S, Kelley JM, Wilhelm M, Miller FG, et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5:1\u201315. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43955.","journal-title":"JAMA Netw Open"},{"key":"3325_CR72","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jama.287.5.622","volume":"287","author":"AJ Barsky","year":"2002","unstructured":"Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622\u20137. https:\/\/doi.org\/10.1001\/jama.287.5.622.","journal-title":"JAMA"},{"key":"3325_CR73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1176\/ajp.145.11.1358","volume":"145","author":"ZJ Lipowski","year":"1988","unstructured":"Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry. 1988;145:1358\u201368. https:\/\/doi.org\/10.1176\/ajp.145.11.1358.","journal-title":"Am J Psychiatry"},{"key":"3325_CR74","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington DC: American Psychiatric Association; 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"3325_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0002-9343(82)90599-X","volume":"72","author":"W Katon","year":"1982","unstructured":"Katon W, Kleinman A, Rosen G. Depression and somatization: a review. Part I Am J Med. 1982;72:127\u201335. https:\/\/doi.org\/10.1016\/0002-9343(82)90599-X.","journal-title":"Part I Am J Med"},{"key":"3325_CR76","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1600-0447.2006.00896.x","volume":"115","author":"G Rubio","year":"2007","unstructured":"Rubio G, L\u00f3pez-Ibor JJ. Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatr Scand. 2007;115:372\u20139. https:\/\/doi.org\/10.1111\/j.1600-0447.2006.00896.x.","journal-title":"Acta Psychiatr Scand"},{"key":"3325_CR77","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.genhosppsych.2008.01.001","volume":"30","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Spitzer RL, Williams JBW, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30:191\u20139. https:\/\/doi.org\/10.1016\/j.genhosppsych.2008.01.001.","journal-title":"Gen Hosp Psychiatry"},{"key":"3325_CR78","doi-asserted-by":"publisher","unstructured":"Alhouri A, Abu Shokor M, Marwa K, Sharabi A, Mohammad Nazir Arrouk D, Al Houri FN, et al. COVID-19 and its impact on healthcare workers: understanding stigma, stress, and quality of life. Cureus. 2023;15. https:\/\/doi.org\/10.7759\/cureus.37846.","DOI":"10.7759\/cureus.37846"},{"key":"3325_CR79","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/S0140-6736(21)01220-4","volume":"397","author":"M Kosaka","year":"2021","unstructured":"Kosaka M, Hashimoto T, Ozaki A, Tanimoto T, Kami M. Delayed COVID-19 vaccine roll-out in Japan. Lancet. 2021;397:2334\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(21)01220-4.","journal-title":"Lancet"},{"key":"3325_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0887-6185(01)00060-3","volume":"15","author":"NS Endler","year":"2001","unstructured":"Endler NS, Kocovski NL. State and trait anxiety revisited. J Anxiety Disord. 2001;15:231\u201345. https:\/\/doi.org\/10.1016\/S0887-6185(01)00060-3.","journal-title":"J Anxiety Disord"},{"key":"3325_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.32598\/IJPCP.27.2.3406.1","volume":"27","author":"S Mohammadi","year":"2021","unstructured":"Mohammadi S, Tajrishi KZ, Tashkeh M. Effect of exercise and meditation on depression and anxiety reduction: a systematic review and meta-analysis. Iran J Psychiatry Clin Psychol. 2021;27:144\u201361. https:\/\/doi.org\/10.32598\/IJPCP.27.2.3406.1.","journal-title":"Iran J Psychiatry Clin Psychol"}],"container-title":["BMC Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-025-03325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-025-03325-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-025-03325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:01:43Z","timestamp":1757466103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychology.biomedcentral.com\/articles\/10.1186\/s40359-025-03325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3325"],"URL":"https:\/\/doi.org\/10.1186\/s40359-025-03325-4","relation":{},"ISSN":["2050-7283"],"issn-type":[{"value":"2050-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Kyoto University Graduate School and Faculty of Medicine (ref No: R3047) and was conducted in accordance with the guidelines of the Declaration of Helsinki. Upon accessing the provided URL, participants found an explanation of the study on the first page, and then they proceeded to the survey after providing their consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"995"}}